Janine Lombard

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci”.

Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac160

N/A

0.513DataRank · unranked

13 citations

Joe Dennis, Jonathan P. Tyrer, Pei-Chen Peng, Simon G. Coetzee, Alberto Luiz P. Reyes +94 more

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07159-9

N/A

0DataRank · unranked

2 citations

Marie Kassapian, Véronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni +12 more

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

ESMO Open(2024)10.1016/j.esmoop.2024.103938

N/A

0DataRank · unranked

9 citations

M. Piccart-Gebhart, Shona Fielding, John Townend, D.W. Hillman, M. Colleoni +37 more